Skip to main content
Fig. 1 | Infectious Agents and Cancer

Fig. 1

From: High Prevalence of Anal Oncogenic Human Papillomavirus Infection in Young Men Who Have Sex with Men Living in Bamako, Mali

Fig. 1

Distribution of the types of anal HPV included (or not included) in the Gardasil-9 vaccine. Number of high-risk (HR) and low-risk (LR) HPV genotypes in 35 anal swabs positive for HPV DNA by molecular biology based on their possible prevention by the 9-valent HPV vaccine study among men who have sex with men (n = 50) living in Mali. Nota bene. The 9-valent Gardasil® vaccine (Merck & Co. Inc., New Jersey, USA) is effective against HPV genotypes 6, 11, 16, 18, 31, 33, 45, 52 and 58

Back to article page